Stock Information
ACADIA Pharmaceuticals Inc (ACAD)
Ticker Symbol: ACAD
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $4,410.70 mil
Piotroski score: 4
PE Ratio: 12.8521
EPS (TTM): 2.2125
Revenue (TTM): $6.59 M
Dividend Yield: N/A%
ROE: 32.39%
Latest News
-
Needham Maintains Buy on ACADIA Pharmaceuticals, Raises Price Target to $41
Wed, Aug 12, 2026 6:05 AM
-
Citigroup Maintains Buy on ACADIA Pharmaceuticals, Raises Price Target to $39
Mon, Aug 10, 2026 11:10 AM
Key Financials
Financial data not available